NPR-A expression and signaling is important for tumor growth and its deficiency has be shown to protect C57BL/6 mice from lung, skin and ovarian cancers, suggesting that NPR-A is a new target for cancer therapy (4,29). Here, NPR1 is linked to ovarian cancer.